Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Lexicon Pharmaceuticals, Inc. (NQ: LXRX)
2.190 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Lexicon Pharmaceuticals, Inc.
 
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Lexicon Announces Proposed $95 Million Common Stock Offering
March 08, 2010
from PR Newswire
Lexicon Pharmaceuticals, Inc. (LXRX) Posts Q4 Loss of $0.13, Wider Y/Y
February 23, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5372998 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Fourth Quarter and Full Year Financial Results
February 23, 2010
Conference Call and Webcast at 11:00 a.m. Eastern Time Read More
from PR Newswire
Lexicon (LXRX) Revises Collaborations with Schering, Organon, Intervet; Entitled to Milestone Payments of Up to $39M Per Drug
February 22, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5371742 for the full story. Read More
from StreetInsider.com News Articles
Market Preview 02-22-10
February 22, 2010
from Wall Street Greek
Lexicon to Report Fourth Quarter and Year End 2009 Financial Results on February 23, 2010
February 16, 2010
Conference Call and Webcast to Follow Read More
from PR Newswire
Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
February 03, 2010
from PR Newswire
Lexicon to Host Conference Call and Webcast to Review Top-Line Phase 2 Results From Diabetes Trial
January 26, 2010
from PR Newswire
Skymark Research Initiates Independent Research Coverage on Lexicon Pharmaceuticals, Inc.
January 21, 2010
from GlobeNewswire News Releases
(OTC: USOG) Acquisition Strategically Close to Bakken Formation
January 21, 2010
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO News Wire. Read More
from Marketwired News Releases
Unusual 11 Mid-Day Movers 01/20: DEAR, TIBB, DIET, PONE Higher; WAVX, CADC, AXU, STEC Lower
January 20, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5260987 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Reports Upbeat Trial Results
January 20, 2010
Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) reported positive results from a Phase II clinical trial of its diabetes treatment LX4211 lifting the stock price 33 cents to $2.30.  ... Read More
from MarketMinute.com Stock News
Morning Movers 01/20: DEAR, TIBB, LXRX, CTZN, PONE, CREE Higher; VRS, NEXM, AXU, SUPX Lower
January 20, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5260249 for the full story. Read More
from StreetInsider.com News Articles
Drug stocks diverge; Shire, Lexicon in spotlight
January 20, 2010
Drug stocks diverge in early action while shares of Shire plc rise following an upgrade by analysts at J.P. Morgan. Read More
category Biotechnology , Analyst , M&A , and 8 more.
from MarketWatch
Markets Open Lower Over Banking Losses
January 20, 2010
Banking losses weighed on investor sentiment to send the markets down to a lower open with the Dow plunging 157 points to 10,567. Nasdaq plummeted 38 points to 2282. Read More
category Market News
from MarketMinute.com Market Updates
Wednesday's biggest gaining and declining stocks
January 20, 2010
Among the shares expected to see active trading in Wednesday's session are those of the major banks – including Bank of America, Bank of New York Mellon, and HSBC – as well as Alcon, Coach, CSX, IBM,... Read More
category RMBS , KFT , BAC , and 16 more.
from MarketWatch
Lexicon Pharma (LXRX) Completes LX4211 Phase 2 in Patients with Type 2 Diabetes Mellitus
January 20, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5259070 for the full story. Read More
from StreetInsider.com News Articles
Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
January 20, 2010
- Significant Improvements in Glycemic Control Read More
from PR Newswire
Thomas Weisel Starts Lexicon (LXRX) at Overweight, $2.50 Price Target
November 23, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5134882 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharma (LXRX) to Present LX1031 Phase 2 Results at GASTRO 2009
November 23, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5132476 for the full story. Read More
from StreetInsider.com News Articles
Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
November 23, 2009
from PR Newswire
Ridgewater Equity Trend and Financial Analysis of Generex Biotechnology Corp., Allscripts-Misys Healthcare Solutions Inc., Lexicon Pharmaceuticals Inc., ATP Oil & Gas Corp., TeleCommunication Systems
November 20, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Ridgewater Equity (RWE). Read More
from Marketwired News Releases
Lexicon's IBS Drug Sees Positive Test Results
November 13, 2009
Lexicon Pharmaceuticals announced positive test results for its phase 2 clinical trials of an irritable bowel syndrome drug. Read More
category Health Care
from FOXBusiness.com
Morning Movers 11/13: CNIC, TSTC, NLST, AGO, SLI Higher; LIME, GMET, BIOF, DISK, MRGE, SSY Lower
November 13, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5106237 for the full story. Read More
from StreetInsider.com News Articles
After-Hours Movers 11/12: TSTC, LXRX, MDSO Higher; DISK, MRNA, LIME, BBI, ESE, JWN Lower
November 12, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5104522 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharma (LXRX) Announces LX1031 Shows Positive Results on Irritable Bowel Syndrome
November 12, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5104182 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome
November 12, 2009
from PR Newswire
Trading Radar for 10/28: First Solar (FSLR), ConocoPhillips (COP), WellPoint (WLP), Goodyear (GT), Int. Paper (IP) Report
October 27, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5048728 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharma (LXRX) Posts Q3 Loss of $0.14
October 27, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5047595 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Third Quarter Financial Results
October 27, 2009
from PR Newswire
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here